McKenna Mark C.

McKenna Mark C.'s trades of Apogee Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-12-16 2024-12-12
B Purchase
12,500 +166.7%
49.85
USD 623,125 		12,500 +166.7% 49.85 USD 623,125
2024-12-16 2024-12-12
B Purchase
7,500 +inf%
49.02
USD 367,650 		7,500 +inf% 49.02 USD 367,650
2023-03-17 2023-03-15
PS Planned sale
25,000 -31.2%
116.14
USD 2,903,500 		25,000 -31.2% 116.14 USD 2,903,500
2023-03-03 2023-03-03
PS Planned sale
10,620 -16.1%
125.13
USD 1,328,881 		10,620 -16.1% 125.13 USD 1,328,881
2023-03-03 2023-03-01
PS Planned sale
700 -1.3%
125.26
USD 87,682 		700 -1.3% 125.26 USD 87,682
2023-02-17 2023-02-17
PS Planned sale
13,680 -19.9%
125.10
USD 1,711,368 		13,680 -19.9% 125.10 USD 1,711,368
2023-02-17 2023-02-16
PS Planned sale
25,000 -31.2%
119.87
USD 2,996,750 		25,000 -31.2% 119.87 USD 2,996,750
2023-02-17 2023-02-15
PS Planned sale
25,000 -31.2%
119.42
USD 2,985,500 		25,000 -31.2% 119.42 USD 2,985,500
2023-01-19 2023-01-17
PS Planned sale
25,000 -31.2%
118.99
USD 2,974,750 		25,000 -31.2% 118.99 USD 2,974,750
// ... existing code ... // ... rest of the file ...